ANNX Stock Cash Flow Statements

Annexon Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Annexon Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30

operating activities:
net income	-25,176,000	-27,891,000	-32,482,000	-35,188,000	-38,676,000	-34,383,000	-35,054,000	-37,137,000	-35,373,000	-37,371,000	-35,598,000	-31,348,000	-26,006,000	-23,193,000	-15,638,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	538,000	538,000	538,000	536,000	536,000	530,000	518,000	540,000	518,000	506,000	559,000	538,000	538,000	276,000	129,000
accretion of discount on available-for-sale securities	-1,137,000					-417,000	-111,000	221,000	380,000		454,000	300,000	180,000
stock-based compensation	4,660,000	4,367,000	4,549,000	4,660,000	4,607,000	4,833,000	4,911,000	4,520,000	4,252,000	4,355,000	4,428,000	4,517,000	2,962,000	1,991,000	1,471,000
reduction in the carrying amount of right-of-use assets	308,000	296,000	285,000	274,000	264,000	488,000	248,000	239,000	230,000	347,000	416,000
changes in operating assets and liabilities:
prepaid expenses and other current assets	-1,629,000	-191,000	725,000	-252,000	1,070,000	-183,000	-1,480,000	817,000	383,000	-847,000	-2,124,000	1,422,000	-1,063,000	84,000	-1,982,000
other non-current assets	-361,000						814,000	-777,000	-241,000
accounts payable	-1,531,000	426,000	-2,351,000	-3,187,000	3,035,000	490,000	-3,446,000	884,000	1,785,000	2,985,000	832,000	-742,000	784,000	-220,000	946,000
accrued liabilities	-3,378,000	-480,000	1,537,000	-1,724,000	-2,771,000	2,137,000	3,305,000	2,596,000	-1,860,000	592,000	828,000	71,000	-718,000	1,848,000	1,531,000
operating lease liabilities	-570,000	-153,000	-506,000	-496,000	-348,000	-848,000	-429,000	-42,000	-412,000	654,000	490,000
other current liabilities	9,000	-129,000	9,000	-223,000	204,000	10,000	6,000	-25,000	50,000
net cash from operating activities	-28,267,000	-23,477,000	-28,291,000	-36,381,000	-32,993,000	-27,139,000	-30,718,000	-28,164,000	-30,288,000	-28,321,000	-29,715,000	-24,658,000	-23,416,000	-19,256,000	-13,584,000
capex	0	-7,000	-20,000	-28,000	-132,000	-290,000	-144,000	-861,000	-4,413,000	-855,000	-803,000	0	-32,000	-172,000	-276,000
free cash flows	-28,267,000	-23,484,000	-28,311,000	-36,409,000	-33,125,000	-27,429,000	-30,862,000	-29,025,000	-34,701,000	-29,176,000	-30,518,000	-24,658,000	-23,448,000	-19,428,000	-13,860,000
investing activities:
purchases of property and equipment		-7,000	-19,000	-30,000	-137,000	-282,000	-169,000	-861,000	-5,214,000	-855,000	-767,000	0	-32,000	-172,000	-276,000
purchases of available-for-sale securities	-100,302,000	-24,476,000	-13,737,000	-38,440,000	-31,435,000	-66,833,000	-18,732,000	-21,697,000	-5,935,000	-34,479,000	-31,506,000	-117,067,000	-42,549,000
proceeds from maturities of available-for-sale securities	23,000,000	22,300,000	61,594,000	44,001,000	51,089,000	23,500,000	32,999,000	42,267,000	79,400,000	71,026,000	29,000,000	28,000,000	5,000,000
net cash from investing activities	-77,302,000	-2,183,000	47,838,000	5,531,000	19,517,000	-43,615,000	14,098,000	19,709,000	68,251,000	33,697,000	-1,278,000	-83,074,000	-37,581,000	-82,872,000	-276,000
financing activities:
proceeds from the exercise of common stock options	198,000	-21,000	0	0	111,000					486,000
proceeds from the issuance of common stock, including related party of zero and 17,995 for the three months ended march 31, 2024 and 2023, respectively	33,131,000
payment of financing costs	-917,000
net cash from financing activities	32,412,000	117,598,000	0	345,000	17,581,000	108,000	122,668,000	113,000	19,000	948,000	-73,000	652,000	268,000	0	259,781,000
increase in cash, cash equivalents and restricted cash	-73,157,000	91,938,000	19,547,000	-30,505,000	4,105,000	-70,646,000	106,048,000	-8,342,000	37,982,000
effect of exchange rate changes on cash, cash equivalents and restricted cash	-12,000	13,000	-2,000	-1,000	-5,000	8,000	-4,000	-6,000	3,000	0	-3,000	-1,000	-1,000
cash, cash equivalents and restricted cash
beginning of period	226,142,000	0	0	0	141,052,000	0	0	0	76,009,000		0	0	268,565,000
end of period	152,973,000	91,951,000	19,545,000	-30,506,000	145,152,000	-70,638,000	106,044,000	-8,348,000	113,994,000		-31,069,000	-107,081,000	207,835,000
supplemental disclosure of cash flow information:
cash paid for amounts included in the measurement of lease liability	1,216,000	1,203,000	1,175,000	1,175,000	1,175,000	7,050,000	1,136,000	757,000	1,135,000	0	252,000
non-cash investing and financing activities:
deferred offering costs included in accounts payable and accrued liabilities	117,000
purchases of property and equipment included in accounts payable and accrued liabilities			-1,000	2,000	5,000	-8,000	25,000
accretion of (discount) premium on available-for-sale securities		-260,000	-595,000
proceeds from employee stock purchase plan purchases		134,000	0
proceeds from the issuance of common stock, pre-funded warrants and common warrants, including related party of 17,995 and 9,500 for the years ended december 31, 2023 and 2022, respectively
proceeds from the issuance of common stock, pre-funded warrants and common warrants, including related party of 948, net of commissions
other assets					-12,000
proceeds from the issuance of common stock to a related party, net of commissions			0	0	17,545,000
payment of common stock issuance costs			0	0	-75,000
proceeds from the issuance of common stock, pre-funded warrants and common warrants in private placement
proceeds from the issuance of common stock, pre-funded warrants and common warrants in private placement - related party
payment of common stock, pre-funded warrants and common warrants issuance costs related to private placement
deferred offering costs included in accrued liabilities
accretion of premium (discount) on available-for-sale securities					-902,000
proceeds from sale of available-for-sale-securities
proceeds from employee stock plan purchases						227,000	0				0
proceeds from the issuance of common stock, pre-funded warrants and common warrants						0
proceeds from the issuance of common stock, pre-funded warrants and common warrants - related party						0
payment of issuance costs related to the issuance of common stock, pre-funded warrants and common warrants						-135,000
right-of-use assets obtained in exchange for lease liability										0	0
construction-in-progress obtained in exchange for tenant improvement allowance from lessors											6,918,000
proceeds from the exercise common stock options							45,000	0	19,000			534,000	268,000
deferred offering costs payment related to the 2021 atm program
purchases of property and equipment included in accrued liabilities									801,000
accretion of discount on available-for sale securities
other long-term assets														0	52,000
deferred rent													-93,000	-95,000	-93,000
proceeds from sale of available-for-sale securities										-1,995,000	1,995,000
proceeds from employee stock purchase plan
proceeds from paycheck protection program loan														0	0
repayments of paycheck protection program loan														0	0
proceeds from issuance of redeemable convertible preferred stock														0
payments of issuance costs related to redeemable convertible preferred stock														0
proceeds from issuance of common stock upon initial public offering, net of underwriting discounts and commissions														0
payments of offering costs related to initial public offering														0
increase in cash, cash equivalents, and restricted cash										6,324,000
cash, cash equivalents, and restricted cash at beginning of year
cash, cash equivalents, and restricted cash at end of year
supplemental disclosures of cash flow information:
reclassification of redeemable convertible preferred stock to common stock upon initial public offering														0
accretion on redeemable convertible preferred stock														0	145,000
leasehold improvements obtained in exchange for tenant improvement allowance from lessors
purchase of property and equipment included in accounts payable and accrued liabilities
beneficial conversion feature recognized upon issuance of redeemable convertible preferred stock														0	0
deemed dividend arising from conversion of beneficial conversion feature														0
deferred offering costs payment
purchase of property and equipment included in accounts payable											-36,000
deferred offering cost payments
proceeds from issuance of redeemable convertible preferred stock, net of issuance costs
net increase in cash, cash equivalents and restricted cash
issuance costs of redeemable convertible preferred stock included in accounts payable and accrued liability
net decrease in cash, cash equivalents and restricted cash													-60,729,000
change in fair value of redeemable convertible preferred stock liability
purchase of available-for-sale securities
net increase in cash and cash equivalents														-102,128,000	245,921,000
effect of exchange rate changes on cash and cash equivalents														7,000	4,000
cash and cash equivalents at beginning of period														0	0
cash and cash equivalents at end of period														-102,121,000	245,925,000
income taxes paid
reclassification of redeemable convertible preferred stock liability to redeemable convertible preferred stock
payment of deferred offering costs
issuance costs of redeemable convertible preferred stock included in accounts payable and accrued liabilities

We provide you with 20 years of cash flow statements for Annexon stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Annexon stock. Explore the full financial landscape of Annexon stock with our expertly curated income statements.

The information provided in this report about Annexon stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.